Skip to main content

Advertisement

Log in

Genome-wide association study of idiopathic hypersomnia in a Japanese population

  • Original Article
  • Published:
Sleep and Biological Rhythms Aims and scope Submit manuscript

Abstract

Idiopathic hypersomnia (IH) is a rare sleep disorder characterized by excessive daytime sleepiness, great difficulty upon awakening, and prolonged sleep time. In contrast to narcolepsy type 1, which is a well-recognized hypersomnia, the etiology of IH remains poorly understood. No susceptibility loci for IH have been identified, although familial aggregations have been observed among patients with IH. Narcolepsy type 1 is strongly associated with human leukocyte antigen (HLA)-DQB1*06:02; however, no significant associations between IH and HLA alleles have been reported. To identify genetic variants that affect susceptibility to IH, we performed a genome-wide association study (GWAS) and two replication studies involving a total of 414 Japanese patients with IH and 6587 healthy Japanese individuals. A meta-analysis of the three studies found no single-nucleotide polymorphisms (SNPs) that reached the genome-wide significance level. However, we identified several candidate SNPs for IH. For instance, a common genetic variant (rs2250870) within an intron of PDE9A was suggestively associated with IH. rs2250870 was significantly associated with expression levels of PDE9A in not only whole blood but also brain tissues. The leading SNP in the PDE9A region was the same in associations with both IH and PDE9A expression. PDE9A is a potential target in the treatment of several brain diseases, such as depression, schizophrenia, and Alzheimer’s disease. It will be necessary to examine whether PDE9A inhibitors that have demonstrated effects on neurophysiologic and cognitive function can contribute to the development of new treatments for IH, as higher expression levels of PDE9A were observed with regard to the risk allele of rs2250870. The present study constitutes the first GWAS of genetic variants associated with IH. A larger replication study will be required to confirm these associations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Billiard M, Sonka K. Idiopathic hypersomnia. Sleep Med Rev. 2016;29:23–33.

    PubMed  Google Scholar 

  2. Ali M, Auger RR, Slocumb NL, Morgenthaler TI. Idiopathic hypersomnia: clinical features and response to treatment. J Clin Sleep Med. 2009;5:562–8.

    PubMed  PubMed Central  Google Scholar 

  3. Anderson KN, Pilsworth S, Sharples LD, et al. Idiopathic hypersomnia: a study of 77 cases. Sleep. 2007;30:1274–81.

    PubMed  PubMed Central  Google Scholar 

  4. Bassetti C, Aldrich MS. Idiopathic hypersomnia. A series of 42 patients. Brain. 1997;120(Pt 8):1423–35.

    PubMed  Google Scholar 

  5. Arnulf I, Leu-Semenescu S, Dodet P. Precision medicine for idiopathic hypersomnia. Sleep Med Clin. 2019;14:333–50.

    PubMed  Google Scholar 

  6. Trotti LM. Idiopathic hypersomnia. Sleep Med Clin. 2017;12:331–44.

    PubMed  PubMed Central  Google Scholar 

  7. Juji T, Satake M, Honda Y, Doi Y. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens. 1984;24:316–9.

    CAS  PubMed  Google Scholar 

  8. Mignot E, Lin L, Rogers W, et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet. 2001;68:686–99.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Miyagawa T, Toyoda H, Kanbayashi T, et al. An association analysis of HLA-DQB1 with narcolepsy without cataplexy and idiopathic hypersomnia with/without long sleep time in a Japanese population. Hum Genome Var. 2015;2:15031.

    PubMed  PubMed Central  Google Scholar 

  10. Nishino S, Ripley B, Overeem S, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000;355:39–40.

    CAS  PubMed  Google Scholar 

  11. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 2002;59:1553–62.

    PubMed  Google Scholar 

  12. Tam V, Patel N, Turcotte M, et al. Benefits and limitations of genome-wide association studies. Nat Rev Genet. 2019;20:467–84.

    CAS  PubMed  Google Scholar 

  13. Miyagawa T, Kawashima M, Nishida N, et al. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet. 2008;40:1324–8.

    CAS  PubMed  Google Scholar 

  14. Hallmayer J, Faraco J, Lin L, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet. 2009;41:708–11.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Miyagawa T, Khor SS, Toyoda H, et al. A variant at 9q34.11 is associated with HLA-DQB1*06:02 negative essential hypersomnia. J Hum Genet. 2018;63:1259–67.

    CAS  PubMed  Google Scholar 

  16. Tadaka S, Katsuoka F, Ueki M, et al. 3.5KJPNv2: an allele frequency panel of 3552 Japanese individuals including the X chromosome. Hum Genome Var. 2019;6:28.

    PubMed  PubMed Central  Google Scholar 

  17. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2011;88:76–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Price AL, Patterson NJ, Plenge RM, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904–9.

    CAS  PubMed  Google Scholar 

  20. Miyagawa T, Nishida N, Ohashi J, et al. Appropriate data cleaning methods for genome-wide association study. J Hum Genet. 2008;53:886–93.

    CAS  PubMed  Google Scholar 

  21. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5: e1000529.

    PubMed  PubMed Central  Google Scholar 

  22. Marchini J, Howie B, Myers S, et al. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet. 2007;39:906–13.

    CAS  PubMed  Google Scholar 

  23. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–5.

    CAS  PubMed  Google Scholar 

  24. Nishida N, Tanabe T, Takasu M, et al. Further development of multiplex single nucleotide polymorphism typing method, the DigiTag2 assay. Anal Biochem. 2007;364:78–85.

    CAS  PubMed  Google Scholar 

  25. Mele M, Ferreira PG, Reverter F, et al. Human genomics. The human transcriptome across tissues and individuals. Science. 2015;348:660–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Pruim RJ, Welch RP, Sanna S, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010;26:2336–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Fromer M, Roussos P, Sieberts SK, et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci. 2016;19:1442–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Fisher DA, Smith JF, Pillar JS, et al. Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J Biol Chem. 1998;273:15559–64.

    CAS  PubMed  Google Scholar 

  29. Kleiman RJ, Chapin DS, Christoffersen C, et al. Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivo. J Pharmacol Exp Ther. 2012;341:396–409.

    CAS  PubMed  Google Scholar 

  30. Yoshida K, Tsunoda SP, Brown LS, Kandori H. A unique choanoflagellate enzyme rhodopsin exhibits light-dependent cyclic nucleotide phosphodiesterase activity. J Biol Chem. 2017;292:7531–41.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Langmesser S, Franken P, Feil S, et al. cGMP-dependent protein kinase type I is implicated in the regulation of the timing and quality of sleep and wakefulness. PLoS ONE. 2009;4: e4238.

    PubMed  PubMed Central  Google Scholar 

  32. Donlea J, Leahy A, Thimgan MS, et al. Foraging alters resilience/vulnerability to sleep disruption and starvation in Drosophila. Proc Natl Acad Sci U S A. 2012;109:2613–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Raizen DM, Zimmerman JE, Maycock MH, et al. Lethargus is a Caenorhabditis elegans sleep-like state. Nature. 2008;451:569–72.

    CAS  PubMed  Google Scholar 

  34. Kanaya HJ, Park S, Kim JH, et al. A sleep-like state in Hydra unravels conserved sleep mechanisms during the evolutionary development of the central nervous system. Sci Adv. 2020. https://doi.org/10.1126/sciadv.abb9415.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Wong ML, Whelan F, Deloukas P, et al. Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response. Proc Natl Acad Sci U S A. 2006;103:15124–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Lee DI, Zhu G, Sasaki T, et al. Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease. Nature. 2015;519:472–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Delhaye S, Bardoni B. Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders. Mol Psychiatry. 2021. https://doi.org/10.1038/s41380-020-00997-9.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Domek-Lopacinska KU, Strosznajder JB. Cyclic GMP and nitric oxide synthase in aging and Alzheimer’s disease. Mol Neurobiol. 2010;41:129–37.

    CAS  PubMed  Google Scholar 

  39. Harms JF, Menniti FS, Schmidt CJ. Phosphodiesterase 9A in brain regulates cGMP signaling independent of nitric-oxide. Front Neurosci. 2019;13:837.

    PubMed  PubMed Central  Google Scholar 

  40. Orom UA, Derrien T, Beringer M, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell. 2010;143:46–58.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Schulz S, Chachami G, Kozaczkiewicz L, et al. Ubiquitin-specific protease-like 1 (USPL1) is a SUMO isopeptidase with essential, non-catalytic functions. EMBO Rep. 2012;13:930–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Bermejo JL, Kabisch M, Dunnebier T, et al. Exploring the association between genetic variation in the SUMO isopeptidase gene USPL1 and breast cancer through integration of data from the population-based GENICA study and external genetic databases. Int J Cancer. 2013;133:362–72.

    CAS  PubMed  Google Scholar 

  43. Toyoda H, Miyagawa T, Koike A, et al. A polymorphism in CCR1/CCR3 is associated with narcolepsy. Brain Behav Immun. 2015;49:148–55.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors are deeply grateful to all participants in the present study.

Funding

This study was supported by a Practical Research Project for Rare/Intractable Diseases grant from the Japan Agency for Medical Research and Development (AMED), Grants-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15H04709 and 19H03588), Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21K07534) and Grants-in-Aid from the Takeda Science Foundation. The funders had no role in study design, data collection, analysis, the decision to publish, or preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Taku Miyagawa.

Ethics declarations

Conflict of interest

Dr. Inoue Yuichi has received grants and payment for lectures, including service on speakers’ bureaus, and has provided expert testimony for MSD K.K., Takeda Pharmaceutical Co. Ltd., and Eisai Co. Ltd. Dr. Makoto Honda has received consulting fees from Takeda Pharmaceutical Co. Ltd. The other authors have no competing interests to declare.

Ethics approval

This research involved human participants. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All individuals provided written informed consent for participation in this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tanida, K., Shimada, M., Khor, SS. et al. Genome-wide association study of idiopathic hypersomnia in a Japanese population. Sleep Biol. Rhythms 20, 137–148 (2022). https://doi.org/10.1007/s41105-021-00349-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s41105-021-00349-2

Keywords

Navigation